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Abstract
Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis (TB), has infected over 1.7 billion people
worldwide and causes 1.4 million deaths annually. Recently, genome sequence analysis has allowed the reconstruction
of Mycobacterium tuberculosis complex (MTBC) evolution, with the identification of seven phylogeographic lineages:
four referred to as evolutionarily “ancient”, and three “modern”. The MTBC strains belonging to “modern” lineages
appear to show enhanced virulence that may have warranted improved transmission in humans over ancient lineages
through molecular mechanisms that remain to be fully characterized. To evaluate the impact of MTBC genetic diversity
on the innate immune response, we analyzed intracellular bacterial replication, inflammatory cytokine levels, and
autophagy response in human primary macrophages infected with MTBC clinical isolates belonging to the ancient
lineages 1 and 5, and the modern lineage 4. We show that, when compared to ancient lineage 1 and 5, MTBC strains
belonging to modern lineage 4 show a higher rate of replication, associated to a significant production of
proinflammatory cytokines (IL-1β, IL-6, and TNF-α) and induction of a functional autophagy process. Interestingly, we
found that the increased autophagic flux observed in macrophages infected with modern MTBC is due to an autocrine
activity of the proinflammatory cytokine IL-1β, since autophagosome maturation is blocked by an interleukin-1
receptor antagonist. Unexpectedly, IL-1β-induced autophagy is not disadvantageous for the survival of modern Mtb
strains, which reside within Rab5-positive phagosomal vesicles and avoid autophagosome engulfment. Altogether,
these results suggest that autophagy triggered by inflammatory cytokines is compatible with a high rate of
intracellular bacilli replication and may therefore contribute to the increased pathogenicity of the modern MTBC
lineages.
Introduction
Mycobacterium tuberculosis (Mtb) emerged as a human
pathogen 75–150 thousand years ago and spread by clonal
expansion among human communities since then, giving
rise to seven phylogeographic lineages which show a
relatively limited genetic variability, consisting of large-
sequence polymorphisms (LSPs) and single-nucleotide
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polymorphisms (SNPs)1–3. The lineages present in the
Mtb complex (MTBC) are distinguished as ancient and
modern. The ancient ones comprise two Mtb lineages
(lineage 1 and the recently identified lineage 7) causing
tuberculosis (TB) in humans, and two M. africanum
lineages, one of which includes bacilli responsible for TB
in animal species4. The modern lineages 2, 3, and 4
consist of Mtb strains responsible for the largest and
deadliest epidemics of the last few centuries and that are
driving the current pandemics in Sub-Saharan Africa,
Southeast Asia, and Eastern Europe, while the ancient
lineage 1 causes TB mainly in the Indo-Oceanic regions
and the Philippines5. Despite the limited genetic varia-
bility within MTBC, the strains belonging to different
lineages show significant differences in terms of patho-
genicity, transmissibility, and host specificity, as high-
lighted by the differences between M. tuberculosis, M.
africanum, and M. bovis strains. Even human-adapted
MTBC strains (Mtb) show phenotypic differences in
terms of intracellular survival and transcriptional profile
in macrophages6–10 and virulence in mice9,10. The impact
of these phenotypic differences between the human-
adapted strains on TB disease and transmission remains
elusive, although the observed sympatric association
between Mtb lineages and ethnic human groups sup-
ported the continuous adaptive process between Mtb and
its host11,12.
The balance between immune activation and inflam-
mation influences the outcome of Mtb infection.
Interferon-γ (IFN-γ) and tumor necrosis factor-α (TNF-
α), mainly produced by type-1 T helper cells, are key
cytokines to contrastMtb infection13,14. IFN-γ production
is regulated by interleukin (IL) 12, which is secreted by
activated phagocytes. Other important proinflammatory
cytokines are IL-1β and IL-6, which may lead to the Th17-
differentiation, as a subset of T cells essential for the
formation of mature pulmonary granulomas13,15.
Although both inflammatory and adaptive responses are
crucial for contrasting mycobacteria infection16–18, the
extensive immune activation may be self-defeating for the
host, paving the way to active TB development and
aggravation13,19,20.
Mtb has developed elaborate survival mechanisms to
persist in the host cells, being able to avoid the immune
system but, at the same time, chronically stimulating it.
The main immune evasion strategies adopted by Mtb are
based on the inhibition of (a) phagolysosomes formation;
(b) antigen processing and presentation to escape from T-
cell surveillance; (c) IFN-γ-signaling pathway; and (d)
autophagy15,21–25.
The role of autophagy during Mtb infection has been
extensively investigated in the last few years. It is well-
known that, besides controlling the turnover of intracel-
lular components, autophagy captures invading pathogens
and delivers them to the lysosome for elimination26. In
this process, target materials are engulfed by double-
membrane vesicles, termed autophagosomes, which
eventually fuse to lysosomes27,28. A specific set of genes,
called ATGs, are dedicated to the regulation of autop-
hagy29. Among them, members of the Atg8 family, e.g.,
LC3, are required for autophagosomal membranes
expansion and closure, as for the selective recognition of
autophagy substrates, including viruses and bacteria, by
interacting with adaptor proteins, such as the sequesto-
some 1/p62-like receptors, which directly bind to cargos30.
Both the innate and adaptive responses required a
functional autophagic process in order to accomplish
their goals31,32. Accordingly, autophagy is strictly regu-
lated by a variety of immune sensors, such as Toll-like
receptors, Nod-like receptors, IRGM, and nucleic-acid
sensors33. Moreover, proinflammatory Th1 cytokines,
such as IFN-γ, TNF-α, and IL-1β, induce autophagy, while
anti-inflammatory Th2 cytokines, such as IL-4 and IL-13
are inhibitory34,35. On the other hand, autophagy gen-
erally plays an inhibitory role on inflammation, either by
eliminating the infectious agent or by physical interaction
of ATG proteins with components of the inflammatory
pathways, contributing in this way to temporally limit the
inflammation response26.
Several evidences show that Mtb can avoid autophagic
degradation and may actually exploit this process to its
own advantage by using multiple strategies36,37. The type-
VII secretion system ESX-1 plays a central role in the
modulation of autophagy by Mtb H37Rv, being respon-
sible for a rapid activation of autophagy by bacterial DNA
through the cytosolic DNA sensor STING38,39, as well as
for the inhibition of autophagosome–lysosome fusion
when infection is established40,41. Importantly, autophagy
stimulation mediated by cytokines and T cells is able to
rescue the block imposed byMtb and favors its killing36,41.
Unexpectedly, recent studies show that, apart from
ATG5, autophagy-deficient mice do not show increased
susceptibility to Mtb42. Although these data appear to
diminish the contribution of basal autophagy in control-
ling Mtb, they are consistent with the reported ability of
this bacterium to effectively inhibit autophagy during
infection25.
Since most of the studies on the host immune response
to Mtb infection have been performed using the labora-
tory strain H37Rv, we decided to characterize whether
genetic variability of Mtb may account for a different
ability to modulate the inflammatory response and
autophagy flux in primary macrophages.
Results
Selection of MTBC strains
To investigate the impact of MTBC genetic diversity
on intracellular growth, inflammatory response, and
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autophagy, six MTBC strains were randomly chosen from
a collection of clinical strains based on their genotype
determined by spoligotyping (Fig. 1a). We selected two
Mtb strains of the ancient phylogeographic lineage 1,
belonging to clades EAI1_SOM and EAI2_Manilla, and a
strain of M. africanum, belonging to the ancient lineage 5,
which includes strains causing TB in a restricted area of
West Africa or in recent immigrants from those
regions5,43. Two strains belonging to the highly successful
phylogeographic lineage 4, of clades H3 and T1, and one
strain from lineage 3, clade CAS1-Kili, were selected as
representative of the modern Mtb strains. We also
included the Mtb reference strain H37Rv, that, while
belonging to the modern lineage 4, has been subjected to
many in vitro passages that may have altered its virulence
properties44. These strains were chosen because they may
fairly represent the genetic diversity of MTBC at the
global level.
Mtb strains belonging to the modern lineage show a
higher rate of intracellular replication
To characterize the virulence properties of the selected
MTBC strains, human monocyte-derived macrophages
(MDM) were infected at MOI 1:1 and intracellular CFUs
were determined at 4 h and 7 days post infection. As
shown in Fig. 1b (upper panel), no significant differences
were observed in the intracellular CFUs at 4 h post
infection, indicating a similar ability of ancient and
modern strains to gain access to macrophages. Analysis of
the intracellular CFUs at day 7 post infection (Fig. 1b,
lower panel) indicated a poor capacity of the two EAI
strains to survive and replicate intracellularly and also the
M. africanum strain showed limited ability to persist in
macrophages. Conversely, all Mtb strains of the modern
clades were capable of replicating intracellularly, with a
similar level of intracellular CFUs. Macrophages infected
with different Mtb strains showed similar viability, as
indicated by evaluating LDH release (data not shown),
indicating that cytotoxicity may not account for the
observed differences of CFUs.
Taken together, these results indicate that the MTBC
strains of the modern clades show enhanced ability to
replicate intracellularly compared to the strains belonging
to the ancient clades.
Mtb strains of modern lineages produce higher levels of
inflammatory cytokines
The levels of inflammatory cytokines upon infection of
human primary macrophages with modern and ancient
MTBC strains were evaluated by cytometry. As shown in
Fig. 2 and S1, infection with the modern lineage strains
induced a higher production of TNF-α, IL-6, IL-1β, and
IL-10 compared to the ancient strains at 5 h (Fig. 2a: p=
0.01, p= 0.0008, p= 0.001, and p= 0.04, respectively),
1 day (Fig. 2b: p= 0.0008, p= 0.01, p= 0.02, and p=
0.0008, respectively) and 3 days post infection (Fig. 2c:
p= 0.02, p= 0.02, p= 0.0004, and p= 0.05, respectively).
These data indicate that a proinflammatory signature is
induced by macrophage infection with modern Mtb
strains.
Mtb strains of the modern lineage 4 induce a functional
autophagy flux
Autophagy flux was analyzed in human primary mac-
rophages infected with the different Mtb strains described
in Fig. 1a by comparing the levels of the autophagosome
Fig. 1 Genetic characterization and replication properties of
MTBC strains from ancient and modern lineages in human
primary macrophages. a Characterization of MTBC lineages by
spoligotyping. b Macrophages were infected with the indicated MTBC
strains. Four hours (upper panel) and 7 days (lower panel) after
infection, cells were lysed to measure the number of viable bacteria by
plating for determining CFU. Values are expressed as a mean of three
independent experiments
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Fig. 2 Evaluation of inflammatory cytokine production in human primary macrophages infected with MTBC strains of ancient and modern
lineages. Cell culture supernatants were collected from macrophages infected with MTBC (MOI 1:1) at 5 h (a), 1 (b), and 3 (c) days. The production of
TNF-α, IL-6, IL-1β, and IL-10 was measured by CBA Flex Set. The results are represented as median of data obtained from modern (H3 and T1) and
ancient (EAI1_SOM, EAI2_MANILLA) Mtb strains. Data obtained from individual MTBC strain infections are reported in Figure S1
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protein LC3-II in the presence or absence of lysosome
inhibitors. In macrophages infected for 24 h with the
ancient Mtb strains, EAI1_SOM, EAI2_Manilla (lineage
1), and AFRI (lineage 5), the inhibition of lysosomal
activity does not result in a significant accumulation of
LC3-II compared to the untreated cells, indicating that
the fusion of autophagosomes with the lysosomes is
impaired (Fig. 3a), similar to what was previously reported
for the laboratory strain H37Rv40,41. Conversely, in mac-
rophages infected with the modern Mtb strains H3 and
T1, the lysosome inhibitors significantly increased LC3-II
levels compared to the untreated cells (Fig. 3b), indicating
that newly formed autophagosomes are efficiently deliv-
ered to the lysosomes in these cells. Similar results were
obtained when autophagic flux was analyzed at 5 h after
infection with ancient and modern Mtb strains (Figure
S2a). Autophagy induction following infection was pre-
vented by using the phosphatidylinositol 3-kinase inhi-
bitor wortmannin, indicating that modern Mtb strains
trigger a canonical autophagic pathway (Figure S2b).
The Mtb H3 strain of lineage 4 evades the autophagy
sequestration
Considering the important contribution of autophagy in
Mtb clearance24, the increased autophagy flux observed in
macrophages infected with the modern strains appeared
to be in contrast with their high rate of replication. These
data prompted us to investigate whether modern Mtb
strains are spared from the autophagosome-mediated
degradation, despite their ability to trigger autophagy.
To this aim, confocal analysis was carried out to eval-
uate the colocalization of mycobacteria with the autop-
hagic marker LC3, as well as with ubiquitin and the
ubiquitin-binding autophagy adaptors NDP52 and NBR1,
which have been reported to mediate the engulfment of
Mtb in autophagosomes39,45. Mtb H3 was chosen as a
representative strain for the modern lineage and com-
pared to H37Rv. As shown in Fig. 4a and S3, Mtb
H3 shows low levels of colocalization with LC3, ubiquitin,
NDP52 and NBR1, indicating that Mtb H3 is not targeted
by autophagy.
Moreover, we tested the ability ofMtb H3 to prevent the
lysosomal degradation, which may occur by the matura-
tion of either phagosomal or autophagosomal compart-
ments. As shown in Fig. 4b, Mtb H3 showed a low level of
colocalization with the lysosomal marker LAMP1, similar
to what was observed in H37Rv-infected cells.
Altogether, our data indicate that, although macrophage
infection with modern Mtb strains leads to an increased
autophagy flux, these bacteria are able to elude the
autophagy machinery.
Recently, Mtb strains belonging to the modern lineages
were reported to have a preferential cytosolic residence in
the infected macrophages, which was proposed as an
alternative adaptation mechanism to avoid the autophagy
degradation46. Thus, we investigated if the autophagy-
resistant properties of the modern Mtb H3 were due to an
increased cytosolic localization. To this aim, confocal
Fig. 3 Analysis of autophagy flux in human primary
macrophages infected with MTBC strains of ancient and modern
lineages. Macrophages were infected with the indicated ancient (a)
or modern (b) MTBC strains and with H37Rv as a reference strain. After
20 h, cells were either incubated with E64d+ PepA to inhibit
lysosome activity or left untreated. Autophagy levels were analyzed
for LC3 expression by immunoblotting. GAPDH levels were analyzed
to normalize the amount of protein loaded (upper panels). LC3-II/
GAPDH ratios were quantified by densitometric analysis using the
ImageQuant software. Each point value represents the mean ± SD
from three independent experiments (lower panels). NI: not infected
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analyses were performed to evaluate the localization of
H37Rv and H3 mycobacteria within Rab5-positive or
CD63-positive endosomal/phagosomal compartments
(Fig. 5a and S4). Our data show that Mtb H3 has a pre-
dominant phagosomal localization, similar to what was
observed in H37Rv-infected cells. Phagosomal localization
of Mtb H3 was also confirmed by performing electron
microscopy analysis (Fig. 5b).
Taken together, these results suggest that, similar to
H37Rv, Mtb H3 is able to prevent its autophagosomal
engulfment by hiding within the phagosomes.
Mtb H3 strain of lineage 4 induces a functional autophagy
flux through IL-1β-dependent signaling
Our data show that modern Mtb strains of lineage 4
induce high levels of IL-1β production and autophagy.
Since IL-1β has been demonstrated to be a powerful
inducer of autophagy in human macrophages47, we
investigated the functional relationship between IL-1β
and autophagy in Mtb H3-infected macrophages.
To this aim, IL-1β activity was blocked using an IL-1
receptor antagonist (IL-1-RA) and autophagy flux eval-
uated by western blot analysis. Notably, IL-1-RA treat-
ment inhibited the autophagic flux in macrophages
infected with Mtb H3, as shown by the reduced increase
of the autophagy markers LC3-II and p62 observed after
the inhibition of the lysosomal activity (Fig. 6). According
to the capability of Mtb H3 to escape the autophagic
response, the inhibition of either IL-1β signaling by IL-1-
RA or the IL-1β-induced autophagic flux by a lysosome
inhibitor did not have an impact on bacterial growth in
infected macrophages (Figure S5).
These data suggest that the different ability of ancient
and modern Mtb to modulate the autophagy flux in
Fig. 4 Analysis of Mtb H3 localization within autophagosomal/autolysosomal vesicles. Primary macrophages were infected with H3 and H37Rv
Mtb. Cells were fixed and analyzed for LC3 (a) or LAMP1 (b) localization by immunofluorescence using specific antibodies, while Mtb was detected by
auramine staining. The images show that the merging of the two fluorescence signals is shown on the left panels. Green: Mtb; red: LC3 in (a), LAMP1
in (b). Scale bar, 6 μm. Colocalization rate was measured by Mander’s coefficient calculated by ImageJ software. Graphics reporting a quantification of
the experiments is shown in the right panels. The results represent the mean ± SD of three independent experiments
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macrophages is associated with their inflammatory
properties.
Discussion
Recent studies have shown the presence of lineage-
specific effects on the outcome of Mtb infection and
disease11. However, how the differences of Mtb genomes
impact on the host response remains poorly character-
ized. Here, we compared ancient and modern MTBC
strains with regard to their ability to replicate in human
macrophages and to modulate innate immune responses
in terms of proinflammatory cytokines and autophagy.
We found that strains of the modern lineages 3 and 4 have
an improved ability to grow in human primary infected
macrophages compared to strains of the ancient lineages
1 and 5. These results are in line with previous findings
showing an enhanced intracellular survival and replication
rate of the strains belonging to the modern lineages when
compared to the reference strains (H37Rv and CDC1551)
and the MTBC strains of the ancient lineages (EAI and
M. africanum), which showed an even less efficient
intracellular survival6,10. However, it should be noted that
differences in the intracellular replication rate have also
been observed between strains belonging to the same
lineage, indicating the presence of both intra-lineage or
intra-genotype variability48,49.
Unexpectedly, a more efficient intracellular replication
is paralleled by an increased production of inflammatory
cytokines and higher levels of autophagy. In detail, we
found that TNF-α, IL-1β, IL-6, and IL-10 levels are higher
in H3 and T1 strains of lineage 4 than in the two EAI
strains from lineage 1 and M. africanum. To note, the
anti-inflammatory cytokine IL-10 is also increased after
H3 and T1 infection. This observation is in agreement
Fig. 5 Analysis of localization Mtb H3 within the endosomal compartment. a Primary macrophages were infected with H3 and H37Rv Mtb. Cells
were fixed and analyzed for Rab5 localization by immunofluorescence using a specific antibody, while Mtb was detected by auramine staining (left
panel). The images show that the merging of the two fluorescence signals is shown on the left panels. Green: Mtb; red: RAB5. Scale bar, 6 μm.
Colocalization rate was measured by Mander’s coefficient calculated by Image J software. Graphics reporting a quantification of the experiments is
shown in the right panel. The results represent the mean ± SD of three independent experiments. b Ultrastructural analysis of Mtb H37Rv and H3-
infected macrophages 24 h post infection. Mycobacteria are indicated by asterisks (×1.500). A magnification of Mtb-containing vesicles is shown in
the panels below (×4.000)
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with the important role proposed for this cytokine in
counterbalancing an excessive innate and adaptive
immune response against Mtb, and could represent an
important target to alter the survival rate of the modern
Mtb strains in macrophages16,50.
It has been previously reported that mycobacteria
belonging to the modern lineages induce a lower immune
response compared to the ancient ones8. In fact, Portevin
and colleagues observed a reduction of proinflammatory
cytokine levels in both macrophages, monocyte-derived
dendritic cells, and murine bone marrow-derived mac-
rophages. Possible differences that may account for this
discrepancy could be represented by the procedure we
used for the ex vivo differentiation of macrophages, which
does not include GM-CSF8, or the difference in the
clinical isolates tested51. In fact, it has been observed that
distinct clinical isolates from the same lineages may dif-
ferently modulate the immune response51.
Activation of proinflammatory responses by Mtb
infection depends on the binding of bacterial components
to extracellular PRRs52 and to the intracellular activation
of the NLRP3 inflammasome53. It has been shown that
differences in surface lipids, sugars, and protein compo-
sitions among Mtb strains may impact the innate immune
responses54–56. Moreover, intracellular pathogen recog-
nition pathways, including IL-1β production via the
NLRP-3 inflammasome and type-I IFNs via the cGAS/
STING pathway, can be differently stimulated according
to the level of secreted EsxA57. It follows that differential
expression or polymorphisms affecting ESX-1 may have
an impact on IL-1β secretion, probably by influencing the
translocation of proteins and otherMtbmetabolites to the
cytosol of infected macrophages58. However, since MTBC
strains belonging to modern and ancient lineages were
shown to differentially induce type-I IFN, despite the fact
that these strains were equally capable of accessing the
cytosol59, it is likely that multiple factors may contribute
to the inflammatory response to different MTBC strains,
as, for example, the extent of the mitochondrial damage.
Activation of IL-1β has been previously shown to pro-
mote Mtb killing through the activation of the TNF-α
signaling, which culminates with caspase-3-induced
apoptosis followed by the uptake and the lysosomal
degradation of Mtb-containing apoptotic bodies by
uninfected neighbors, a process defined as effer-
ocytosis60,61. In addition, IL-1β is also known to induce
autophagy that in turn has been shown to restrict Mtb
replication in macrophages47. In line with these observa-
tions, the H3 and T1 strains, which trigger a higher level
of IL-1β compared with ancient and reference strains,
induce a functional autophagic process, as shown by
analyzing the degradation rate of the autophagosomal
marker LC3II. Conversely, cells infected with ancient
MTBC strains and H37Rv, secrete lower levels of IL-1β
and show an inhibited autophagic flux. Notably, we found
that the increased production of IL-1β was indeed
responsible for the induction of autophagy, since an
inhibitor of IL-1β prevented autophagy flux in H3-
infected macrophages, reestablishing the block of autop-
hagosome maturation observed with H37Rv and the
ancient strains. However, despite the higher autophagy
induction and consistent with its increased ability to
survive in macrophages, Mtb H3 strain is able to hide
within endosomal compartments and to elude autopha-
gosome engulfment and consequent lysosomal degrada-
tion. Understanding the molecular mechanisms that allow
modern Mtb strains to escape IL-1β-induced autophagy
degradation will be relevant to design novel therapeutic
strategies aimed at preventing their intracellular survival.
The fact that several drugs specifically targeting autop-
hagy, inflammation, and immunometabolism have been
shown to exert anti-TB activity highlights the potential
Fig. 6 Role of IL-1β on the induction of autophagy triggered by
Mtb H3. Macrophages were infected with the Mtb H3 and H37Rv
strains. After 2 h, uninfected and infected cells were treated with an IL-
1β receptor antagonist or left untreated. After 20 h, cells were
incubated with E64d+ PepA to inhibit lysosome activity or left
untreated. Autophagy levels were analyzed by evaluating LC3 and p62
expression by immunoblotting. GAPDH levels were analyzed to verify
protein amount loading (upper panels). LC3-II/GAPDH ratios were
quantified by densitometric analysis using the ImageQuant software.
Each point value represents the mean ± SD from three independent
experiments (lower panel)
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consequences of these studies in terms of development of
new host-directed therapies against TB62–64.
Modulation of IL-1β and autophagy levels may have a
relation with the increased virulence observed in strains of
modern lineages. In fact, IL-1β is required for protection
against TB but a chronic high level of IL-1β is associated
with pathology, likely causing a non-protective
response65. At the same time, IL-1β-induced autophagy
could turn out to be beneficial for chronic infection by
sustaining macrophages metabolism66 and protecting
against excessive inflammation during Mtb infection67. In
this line, it has been recently proposed that Mtb may
selectively regulate autophagy to extend survival in
infected macrophages68. This hypothesis is also supported
by our observation that infection with modernMtb strains
does not result in decreased macrophage viability, which
would have been expected in cells infected with highly
replicating Mtb strains. Hence, the ability of modern Mtb
strains to efficiently replicate intracellularly in macro-
phages, while inducing autophagy, may represent an
advantage acquired during evolution to enhance bacilli
persistence in inflammed host tissues. Potential limita-
tions of the present study should be considered. We
analyzed a relatively small number of clinical isolates.
However, although larger studies are needed to confirm
these observations, the data generated here on the mod-
ulation of the autophagy process are confirmed by dif-
ferent approaches such as immunoblotting, confocal, and
electron microscopy.
In view of these findings, it will be important to test how
the different ability of modern Mtb strains to alter
autophagy and inflammation impacts on the regulation of
specific T-cell response. This is expected to uncover new
aspects on the complex mechanism that allows Mtb to
escape the immune response and be protected from
vaccinal approaches. The results of this study may have
translational implications for the design of new TB vac-
cines or host-directed therapies, which should take into
account both the autophagic and immunogenic char-
acteristics of the lineage of the Mtb candidate.
Materials and methods
MTBC strains
The MTBC strains used in this study were selected from
a collection of clinical strains isolated at the Università
Cattolica del Sacro Cuore in Rome and Mtb H37Rv was
used as a reference strain. The MTBC strains were grown
in Middlebrook 7H9 (Difco BD, NY) medium supple-
mented with 0.2% glycerol, 10% ADC (bovine albumin
fraction V, dextrose, and catalase; Microbiol [Cagliari,
Italy]), and 0.05% Tween 80 (Sigma-Aldrich, St. Louis,
MO) at 37 °C. Mycobacterial cultures were harvested at
late log phase, glycerol was added at 20% final con-
centration, and 1-ml aliquots were stored at –80 °C.
Genomic DNA was extracted from liquid cultures by
using the CTAB method, as previously described69.
Phylogenetic analysis of MTBC strains
The genomic DNA of each MTBC clinical strain was
genotyped by spoligotyping70. For each experimental
session, genomes of Mtb H37Rv and M. bovis BCG were
used as positive controls and water as negative control.
Macrophage culture
Peripheral blood mononuclear cells (PBMCs) were
obtained from healthy donors. PBMCs were isolated by
density-gradient centrifugation. Monocytes were purified
from PBMCs by positive sorting, using anti-CD14-
conjugated magnetic microbeads (Miltenyi Biotec,
Auburn, CA). After the selection, the level of purification
was verified by flow cytometry (FACS Canto II flow cyt-
ometer; Becton Dickinson, Milan, Italy): 99% of CD14+
monocytes and 1% of CD3+T cells. Macrophage-derived
monocytes (MDM) were obtained by cultivating adherent
monocytes for 5–6 days in X-Vivo 15 medium (Lonza,
Walkersville, MD) and 2% human serum (Euroclone,
Paignton, UK) at 37 °C in a 5% humidified atmosphere
until macrophage differentiation.
Depending on the experimental requirements, different
amount of cells were used. In detail, for the western blot
experiments, the cells were seeded in six-well flat-bottom
tissue culture plates (3 × 106 cells/well, 2 ml/well; Corn-
ing, New York, NJ). For the confocal experiments, cells
were seeded in glass slide chambers (Nunc, Lab-Tek,
Waltham, Massachusetts, USA) (5 × 105 cells/well, 2 ml/
well). For the colony-forming unit (CFU) experiment,
cells were seeded in 24-well flat-bottom tissue culture
plates (5 × 105 cells/well, 1 ml/well; Corning, New York,
NJ). For electron microscopy, cells were seeded in 60-mm
tissue culture plates (5.5 × 106 cells; Corning, New York,
NJ).
Autophagy was evaluated both 5 and 24 h after infec-
tion. To assess the autophagy flux, the lysosomal inhibi-
tors E64d/pepstatin A (5 µg/ml; Sigma-Aldrich, St. Louis,
MO), were added 4 h before lysis. Wortmannin (20 nM
Sigma-Aldrich, St. Louis, MO) was added 5 h before lysis.
To inhibit IL-1b activity, soluble antagonist for IL-1
receptor (IL-1-RA) at 1 µg/ml (R&D, Minneapolis, MN)
was added to the macrophage cultures before infection.
IL-1-RA was added again after the infection, con-
comitantly to the medium change; the uninfected cells
followed the same treatment71.
To evaluate the viability of the MTBC-infected macro-
phages, the LDH Cytotoxicity Assay Kit (Thermo Fisher,
Waltham, MA, USA) was used. The LDH Cytotoxicity
Assay Kit is a reliable colorimetric assay to quantitatively
measure lactate dehydrogenase (LDH) released into the
Romagnoli et al. Cell Death and Disease  (2018) 9:624 Page 9 of 12
Official journal of the Cell Death Differentiation Association
media from damaged cells as a biomarker for cellular
cytotoxicity and cytolysis.
MTBC infection of macrophages and colony-forming unit
assay
Macrophages were infected with different MTBC
strains (HR7Rv, EAI1_SOM, EAI2_MANILLA, AFRI, H3,
and T1) at a multiplicity of infection (MOI) of 1:1 for
western blot analysis and CFU and at a MOI of 2:1 for
confocal experiments and electron microscopy. Two
hours after the in vitro infection, macrophages were
washed once with phosphate-buffered saline (PBS) and
then fresh medium was added.
To determine the intracellular bacterial load, CFUs of
infected macrophages were measured in triplicate and
determined at 4 h and 7 day post infection55. Briefly,
infected cell cultures were lysed in PBS 0.1%, Triton X
(Sigma-Aldrich, St. Louis, MO), and the serial dilution
was prepared in PBS 0.05% Tween 80 (Sigma-Aldrich, St.
Louis, MO). Fifty-microliter aliquots of each dilution were
plated on 7H11/OADC (Difco BD, NY) agar plates. The
plates were incubated for 3 weeks.
Western blot assays
Cells were collected 5 and 24 h post infection and lysed
in CelLytic buffer (Sigma-Aldrich, St. Louis, MO) plus the
following protease and phosphatase inhibitors: protease
inhibitor cocktail, 1 mM sodium fluoride, 1 mM sodium
orthovanadate, and 1 mM sodium molybdate; 1 mM
phenylmethylsulfonyl fluoride (Sigma-Aldrich, St. Louis,
MO). Proteins were resolved on 12% NuPAGE Bis-Tris
gel (Life Technologies, Carlsbad, CA) and electroblotted
onto PVDF membranes (Millipore, Billerica, MA). Blots
were incubated with primary antibodies in 5% nonfat
dry milk in PBS plus 0.1% Tween-20 (Sigma-Aldrich,
St. Louis, MO) overnight at 4 °C. Proteins were detected
using horseradish peroxidase-conjugated secondary
antibody (Jackson Laboratory, Bar Harbor, ME) and
visualized with ECL plus (GE Healthcare, Little Chalfont,
UK).
The primary antibodies used in this study were rabbit
anti-LC3 (Cell Signaling, Danvers, MA) (1:2000), mouse
anti-p62 (Santa Cruz Biotech, Santa Cruz, CA) (1:1000),
and goat anti-GAPDH (Santa Cruz Biotech, Santa Cruz,
CA) (1:50,000).
Confocal microscopy
Twenty-four hours after infection, cells were fixed with
4% paraformaldehyde (Sigma-Aldrich, St. Louis, MO) in
PBS followed by permeabilization with 0.2% Triton X-100
(Sigma-Aldrich, St. Louis, MO) in PBS. Mycobacteria
were stained with auramine for 20min and destained for
10min (TB Fluorescent Stain Kit BD, Sparks, MD). Cells
were then labeled with the primary antibody anti-LC3
(L7543, Sigma-Aldrich, St. Louis, MO), anti-LAMP1 (Ab-
24170, Abcam, Cambridge, UK) and anti-Rab5a (S-19,
Santa Cruz Biotech, Santa Cruz, CA), anti-NDP52 (Ab-
184688, Abcam, Cambridge, UK), anti-CD63 (MX-
49.129.5, Santa Cruz Biotech, CA), anti-NBR1 (NBP1-
71703, Novus Biological, Littleton, Colorado, CA), and
anti-ubiquitin (FK2) (ST1200, Millipore, Billerica, MA)
for 1 h at room temperature and visualized by means of
Cy3-conjugated secondary antibodies (Jackson Immu-
noresearch). Coverslips were mounted in Prolong Gold
antifade (Life Technologies, Carlsbad, CA) and examined
under a confocal microscope (Leica TCS SP2, Wetzlar,
Germany). Digital images were acquired with the Leica
software and the image adjustments and merging were
performed by using the appropriated tools of ImageJ
software. Quantification of colocalization, expressed in
terms of Mander’s coefficient, was calculated using the
JacoP plugin of ImageJ software. A minimum of 50 cells
per sample experimental condition were counted for tri-
plicate samples per condition in each experiment.
Cytokine detection
Supernatants from MTBC-infected macrophage cul-
tures were collected at different time points after in vitro
infection and cytokines were evaluated by a cytometric
bead array (BD Biosciences, San Jose, CA).
Electron microscopy
Twenty-four hours after infection, cells were fixed on
ice with 2.5% glutaraldehyde in 0.1M cacodylate buffer,
pH 7.4, for 120min and postfixed with 1% osmium tet-
raoxide for 120 min at 4 °C. After an extensive washing
with cacodylate buffer at 0.1M, pH 7.4, cells were dehy-
drated in graded concentrations of ethanol (30, 50, 70, 90,
and 100%) and finally embedded in Spurr resin (TAAB).
Ultrathin sections (60 nm) were subsequently cut with a
PT-PC PowerTome ultramicrotome (RMC Boeckeler).
Sections, collected on copper grids, were stained with
saturated aqueous uranyl acetate and counterstained with
4% lead citrate, and then observed with HT-7700 TEM
(Hitachi, Tokyo, Japan).
Statistical analysis
Data were analyzed by the GraphPad Prism software,
version 4.00 for Windows (GraphPad Software, San
Diego, CA). For all the experiments shown, with the
exception of the cytokine results, the data were evaluated
by analyzing the mean and standard deviation. The sta-
tistical significance of the differences between two groups
was determined using the Student’s t-test. For the cyto-
kine results, data are analyzed evaluating the median and
P-values were calculated using the Mann–Whitney test.
Differences were considered significant if P-values were
≤0.05.
Romagnoli et al. Cell Death and Disease  (2018) 9:624 Page 10 of 12
Official journal of the Cell Death Differentiation Association
Acknowledgements
This work was supported in part by grants from the Italian Ministry of
University and Research (PRIN 20152CB22L), from the Italian Ministry of Health
“Ricerca Corrente” and “Ricerca Finalizzata” (GR-2011-02350886; RF-2011-
02348713; RF-2011-02349394), from the European Union (HEALTH-F3-2009-
241642, contract no. HEALTH.F3.2009 241745, and EC FP7 NEWTBVAC), and
from “Accordo Programma Quadro––Ricerca Regione Puglia” Future in
Research VPSBGE1.
Author details
1Department of Epidemiology and Preclinical Research, National Institutes for
Infectious Diseases Lazzaro Spallanzani IRCCS, Rome 00149, Italy. 2Institute of
Microbiology, Universita’ Cattolica del Sacro Cuore – Fondazione Policlinico
Gemelli, Rome 00168, Italy. 3Dipartimento di Scienze e Tecnologie Biologiche
ed Ambientali, University of Salento, Lecce 73100, Italy
Conflict of interest
The authors declare that they have no conflict of interest.
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Supplementary Information accompanies this paper at https://doi.org/
10.1038/s41419-018-0640-8.
Received: 25 July 2017 Revised: 16 April 2018 Accepted: 17 April 2018
References
1. Brosch, R. et al. A new evolutionary scenario for the Mycobacterium tubercu-
losis complex. Proc. Natl Acad. Sci. USA 99, 3684–3689 (2002).
2. Wirth, T. et al. Origin, spread and demography of the Mycobacterium tuber-
culosis complex. PLoS Pathog. 4, e1000160 (2008).
3. Hershberg, R. et al. High functional diversity in Mycobacterium tuberculosis
driven by genetic drift and human demography. PLoS Biol. 6, e311 (2008).
4. Brites, D. & Gagneux, S. Co-evolution of Mycobacterium tuberculosis and Homo
sapiens. Immunol. Rev. 264, 6–24 (2015).
5. Coscolla, M. & Gagneux, S. Consequences of genomic diversity in Myco-
bacterium tuberculosis. Semin. Immunol. 26, 431–444 (2014).
6. Homolka, S., Niemann, S., Russell, D. G. & Rohde, K. H. Functional genetic
diversity among Mycobacterium tuberculosis complex clinical isolates: deli-
neation of conserved core and lineage-specific transcriptomes during intra-
cellular survival. PLoS Pathog. 6, e1000988 (2010).
7. Sarkar, R., Lenders, L., Wilkinson, K. A., Wilkinson, R. J. & Nicol, M. P. Modern
lineages of Mycobacterium tuberculosis exhibit lineage-specific patterns of
growth and cytokine induction in human monocyte-derived macrophages.
PLoS ONE 7, e43170 (2012).
8. Portevin, D., Gagneux, S., Comas, I. & Young, D. Human macrophage responses
to clinical isolates from the Mycobacterium tuberculosis complex discriminate
between ancient and modern lineages. PLoS Pathog. 7, e1001307 (2011).
9. Krishnan, N. et al. Mycobacterium tuberculosis lineage influences innate
immune response and virulence and is associated with distinct cell envelope
lipid profiles. PLoS ONE 6, e23870 (2011).
10. Reiling, N. et al. Clade-specific virulence patterns of Mycobacterium tuberculosis
complex strains in human primary macrophages and aerogenically infected
mice. MBio 4, https://doi.org/10.1128/mBio.00250-13 (2013).
11. Gagneux, S. Host-pathogen coevolution in human tuberculosis. Philos. Trans. R.
Soc. Lond. B Biol. Sci. 367, 850–859 (2012).
12. Gagneux, S. Ecology and evolution of Mycobacterium tuberculosis. Nat. Rev.
Microbiol. 16, 202–213 (2018).
13. Lyadova, I. V. & Panteleev, A. V. Th1 and Th17 cells in tuberculosis: protection,
pathology, and biomarkers. Mediat. Inflamm. 2015, 854507 (2015).
14. Prezzemolo, T. et al. Functional signatures of human CD4 and CD8 T cell
responses to Mycobacterium tuberculosis. Front. Immunol. 5, 180 (2014).
15. Ottenhoff, T. H. New pathways of protective and pathological host defense to
mycobacteria. Trends Microbiol. 20, 419–428 (2012).
16. Flynn, J. L., Chan, J. & Lin, P. L. Macrophages and control of granulomatous
inflammation in tuberculosis. Mucosal Immunol. 4, 271–278 (2011).
17. Boom, W. H. et al. Human immunity to M. tuberculosis: T cell subsets and
antigen processing. Tuberculosis 83, 98–106 (2003).
18. Kaufmann, S. H. Tuberculosis: Back on the immunologists’ agenda. Immunity
24, 351–357 (2006).
19. Fletcher, H. A. et al. T-cell activation is an immune correlate of risk in BCG
vaccinated infants. Nat. Commun. 7, 11290 (2016).
20. Petruccioli, E. et al. Correlates of tuberculosis risk: predictive biomarkers for
progression to active tuberculosis. Eur. Respir. J. 48, 1751–1763 (2016).
21. Flynn, J. L. & Chan, J. Immune evasion by Mycobacterium tuberculosis: living
with the enemy. Curr. Opin. Immunol. 15, 450–455 (2003).
22. Rohde, K., Yates, R. M., Purdy, G. E. & Russell, D. G. Mycobacterium tuberculosis
and the environment within the phagosome. Immunol. Rev. 219, 37–54
(2007).
23. Sahiratmadja, E. et al. Dynamic changes in pro- and anti-inflammatory cyto-
kine profiles and gamma interferon receptor signaling integrity correlate with
tuberculosis disease activity and response to curative treatment. Infect. Immun.
75, 820–829 (2007).
24. Gutierrez, M. G. et al. Autophagy is a defense mechanism inhibiting BCG and
Mycobacterium tuberculosis survival in infected macrophages. Cell 119,
753–766 (2004).
25. Goletti, D., Petruccioli, E., Romagnoli, A., Piacentini, M. & Fimia, G. M. Autophagy
in Mycobacterium tuberculosis infection: a passepartout to flush the intruder
out? Cytokine Growth Factor Rev. 24, 335–343 (2013).
26. Deretic, V., Saitoh, T. & Akira, S. Autophagy in infection, inflammation and
immunity. Nat. Rev. Immunol. 13, 722–737 (2013).
27. Mizushima, N. & Komatsu, M. Autophagy: renovation of cells and tissues. Cell
147, 728–741 (2011).
28. Antonioli, M., Di Rienzo, M., Piacentini, M. & Fimia, G. M. Emerging mechanisms
in initiating and terminating autophagy. Trends Biochem. Sci. 42, 28–41
(2017).
29. Mizushima, N., Yoshimori, T. & Ohsumi, Y. The role of Atg proteins in autop-
hagosome formation. Annu. Rev. Cell. Dev. Biol. 27, 107–132 (2011).
30. Rogov, V., Dotsch, V., Johansen, T. & Kirkin, V. Interactions between autophagy
receptors and ubiquitin-like proteins form the molecular basis for selective
autophagy. Mol. Cell 53, 167–178 (2014).
31. Kuballa, P., Nolte, W. M., Castoreno, A. B. & Xavier, R. J. Autophagy and the
immune system. Annu. Rev. Immunol. 30, 611–646 (2012).
32. Shibutani, S. T., Saitoh, T., Nowag, H., Munz, C. & Yoshimori, T. Autophagy and
autophagy-related proteins in the immune system. Nat. Immunol. 16,
1014–1024 (2015).
33. Deretic, V. Autophagy as an innate immunity paradigm: expanding the scope
and repertoire of pattern recognition receptors. Curr. Opin. Immunol. 24, 21–31
(2012).
34. Harris, J. Autophagy and cytokines. Cytokine 56, 140–144 (2011).
35. Harris, J. et al. T helper 2 cytokines inhibit autophagic control of intracellular
Mycobacterium tuberculosis. Immunity 27, 505–517 (2007).
36. Deretic, V. et al. Immunologic manifestations of autophagy. J. Clin. Invest. 125,
75–84 (2015).
37. Stanley, S. A. & Cox, J. S. Host-pathogen interactions during Mycobacterium
tuberculosis infections. Curr. Top. Microbiol. Immunol. 374, 211–241 (2013).
38. Watson, R. O. et al. The cytosolic sensor cGAS detects Mycobacterium tuber-
culosis DNA to induce type I interferons and activate autophagy. Cell. Host.
Microbe 17, 811–819 (2015).
39. Watson, R. O., Manzanillo, P. S. & Cox, J. S. Extracellular M. tuberculosis DNA
targets bacteria for autophagy by activating the host DNA-sensing pathway.
Cell 150, 803–815 (2012).
40. Romagnoli, A. et al. ESX-1 dependent impairment of autophagic flux by
Mycobacterium tuberculosis in human dendritic cells. Autophagy 8, 1357–1370
(2012).
41. Petruccioli, E. et al. Specific T cells restore the autophagic flux inhibited by
Mycobacterium tuberculosis in human primary macrophages. J. Infect. Dis. 205,
1425–1435 (2012).
42. Kimmey, J. M. et al. Unique role for ATG5 in neutrophil-mediated immuno-
pathology during M. tuberculosis infection. Nature 528, 565–569 (2015).
43. de Jong, B. C., Antonio, M. & Gagneux, S. Mycobacterium africanum–review of
an important cause of human tuberculosis in WestAfrica. PLoS Negl. Trop. Dis.
4, e744 (2010).
44. Collins, F. M. Tuberculosis research in a cold climate. Tuber. Lung Dis. 78,
99–107 (1997).
Romagnoli et al. Cell Death and Disease  (2018) 9:624 Page 11 of 12
Official journal of the Cell Death Differentiation Association
45. Franco, L. H. et al. The ubiquitin ligase Smurf1 functions in selective autophagy
of Mycobacterium tuberculosis and anti-tuberculous host defense. Cell Host
Microbe 21, 59–72 (2017).
46. Jamwal, S. V. et al. Mycobacterial escape from macrophage phagosomes to
the cytoplasm represents an alternate adaptation mechanism. Sci. Rep. 6,
23089 (2016).
47. Pilli, M. et al. TBK-1 promotes autophagy-mediated antimicrobial defense by
controlling autophagosome maturation. Immunity 37, 223–234 (2012).
48. Ribeiro, S. C. et al.Mycobacterium tuberculosis strains of the modern sublineage
of the Beijing family are more likely to display increased virulence than strains
of the ancient sublineage. J. Clin. Microbiol. 52, 2615–2624 (2014).
49. Theus, S. A. et al. Differences in the growth of paired Ugandan isolates of
Mycobacterium tuberculosis within human mononuclear phagocytes correlate
with epidemiological evidence of strain virulence. Infect. Immun. 74,
6865–6876 (2006).
50. Etna, M. P., Giacomini, E., Severa, M. & Coccia, E. M. Pro- and anti-inflammatory
cytokines in tuberculosis: a two-edged sword in TB pathogenesis. Semin.
Immunol. 26, 543–551 (2014).
51. Tientcheu, L. D. et al. Immunological consequences of strain variation within
the Mycobacterium tuberculosis complex. Eur. J. Immunol. 47, 432–445 (2017).
52. Mortaz, E. et al. Interaction of pattern recognition receptors with Myco-
bacterium Tuberculosis. J. Clin. Immunol. 35, 1–10 (2015).
53. Mishra, A., Akhtar, S., Jagannath, C. & Khan, A. Pattern recognition receptors
and coordinated cellular pathways involved in tuberculosis immunopatho-
genesis: Emerging concepts and perspectives. Mol. Immunol. 87, 240–248
(2017).
54. Reed, M. B. et al. A glycolipid of hypervirulent tuberculosis strains that inhibits
the innate immune response. Nature 431, 84–87 (2004).
55. Palucci, I. et al. PE_PGRS33 contributes to Mycobacterium tuberculosis entry
in macrophages through interaction with TLR2. PLoS ONE 11, e0150800
(2016).
56. Manca, C. et al. Mycobacterium tuberculosis CDC1551 induces a more vigorous
host response in vivo and in vitro, but is not more virulent than other clinical
isolates. J. Immunol. 162, 6740–6746 (1999).
57. Wassermann, R. et al. Mycobacterium tuberculosis differentially activates cGAS-
and inflammasome-dependent intracellular immune responses through ESX-
1. Cell Host Microbe 17, 799–810 (2015).
58. Simeone, R., Bottai, D., Frigui, W., Majlessi, L., & Brosch, R. ESX/type VII secretion
systems of mycobacteria: Insights into evolution, pathogenicity and protec-
tion. Tuberculosis 95 (Suppl 1), S150–S154 (2015).
59. Wiens, K. E. & Ernst, J. D. The mechanism for type I interferon induction by
Mycobacterium tuberculosis is bacterial strain-dependent. PLoS. Pathog. 12,
e1005809 (2016).
60. Martin, C. J. et al. Efferocytosis is an innate antibacterial mechanism. Cell Host
Microbe 12, 289–300 (2012).
61. Jayaraman, P. et al. IL-1beta promotes antimicrobial immunity in macrophages
by regulating TNFR signaling and caspase-3 activation. J. Immunol. 190,
4196–4204 (2013).
62. Zumla, A. et al. Towards host-directed therapies for tuberculosis. Nat. Rev. Drug.
Discov. 14, 511–512 (2015).
63. Kaufmann, S. H. E., Dorhoi, A., Hotchkiss, R. S. & Bartenschlager, R. Host-directed
therapies for bacterial and viral infections. Nat. Rev. Drug. Discov. 17, 35–56
(2018).
64. Palucci, I. et al. Transglutaminase type 2 plays a key role in the pathogenesis of
Mycobacterium tuberculosis infection. J. Intern. Med. 283, 303–313 (2018).
65. Bradfute, S. B. et al. Autophagy as an immune effector against tuberculosis.
Curr. Opin. Microbiol. 16, 355–365 (2013).
66. O’Neill, L. A. & Pearce, E. J. Immunometabolism governs dendritic cell and
macrophage function. J. Exp. Med. 213, 15–23 (2016).
67. Castillo, E. F. et al. Autophagy protects against active tuberculosis by sup-
pressing bacterial burden and inflammation. Proc. Natl Acad. Sci. USA 109,
E3168–E3176 (2012).
68. Chandra, P. et al. Mycobacterium tuberculosis inhibits RAB7 recruitment to
selectively modulate autophagy flux in macrophages. Sci. Rep. 5, 16320 (2015).
69. van Embden, J. D. et al. Strain identification of Mycobacterium tuberculosis by
DNA fingerprinting: recommendations for a standardized methodology. J.
Clin. Microbiol. 31, 406–409 (1993).
70. Kamerbeek, J. et al. Simultaneous detection and strain differentiation of
Mycobacterium tuberculosis for diagnosis and epidemiology. J. Clin. Microbiol.
35, 907–914 (1997).
71. Goletti, D., Kinter, A. L., Hardy, E. C., Poli, G. & Fauci, A. S. Modulation of
endogenous IL-1 beta and IL-1 receptor antagonist results in opposing effects
on HIV expression in chronically infected monocytic cells. J. Immunol. 156,
3501–3508 (1996).
Romagnoli et al. Cell Death and Disease  (2018) 9:624 Page 12 of 12
Official journal of the Cell Death Differentiation Association
